Cipla Medpro rises to record high

Comment on this story
Pharma REUTERS A pharmacist counts pills in a pharmacy.

Johannesburg - Shares in Cipla Medpro rise to a record high as investors bet its Indian suitor Cipla Ltd is likely to raise its $215 million offer for control of the South African generic drug firm.

Cipla Medpro, which has been trading since mid-December above the 8.55 rand per share offer that Cipla Ltd put on the table in November 2012, is up 0.5 percent at 9.45 rand.

“The market is telling you that Cipla Ltd is going to have to raise the price,” said Andrew Bryson, a trader at BoE Stockbrokers.

Johannesburg stock market players has been betting on a sweetened offer from Cipla Ltd for months after Cipla Medpro won a lucrative state contract that will boost its earnings. - Reuters

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines